Over the past decade, several molecular diagnostic tests have been developed for thyroid FNA biopsy samples. Tests currently marketed in the United States include Afirma GSC and Xpression Atlas (Veracyte), ThyroSeq (Sonic Healthcare USA), and ThyGeNEXT / ThyraMIR (Interpace Diagnostics). This webinar will highlight established and emerging roles of molecular testing in the clinical evaluation of thyroid nodules, provide a framework for understanding the different molecular approaches (i.e., genotyping, mRNA expression, microRNA expression) for risk-stratifying thyroid aspirates, and compare the strengths, limitations, and applications of the commercially available tests listed above.
- Provider:American Society of Cytopathology
- Activity Link: https://education.cytopathology.org/
- Start Date: 2023-10-24 05:00:00
- End Date: 2023-10-24 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABPATH - 2.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cytopathology
Subscribe
Login
0 Comments
Oldest